Literature DB >> 13454688

Intermediate reactions in the coagulation of blood with tissue thromboplastin; convertin, accelerin, prothrombinase.

P F HJORT.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION

Mesh：

Substances：

Year:  1957        PMID： 13454688

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN： 0036-5513            Impact factor:   1.713


× No keyword cloud information.
  15 in total

1.  [THE PROPORTION OF ANTIHEMOPHILIC FACTORS: BIOLOGICAL AND GENETIC CORRELATION WAS DETERMINED ON 55 SUBJECTS].

Authors:  P D AUTEUIL; R AUTHIER; M SIROIS
Journal:  Can Med Assoc J       Date:  1964-11-07       Impact factor: 8.262

2.  [The progressive effective inhibitors of blood coagulation following Marcumar poisoning].

Authors:  K SCHIMPF
Journal:  Klin Wochenschr       Date:  1963-03-15

3.  The role of proconvertin and Stuart factor in the inactivation of tissue thromboplastin by serum.

Authors:  F HERMANSKY; J VITEK
Journal:  Experientia       Date:  1960-10-15

4.  The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide.

Authors:  R T Breckenridge; O D Ratnoff
Journal:  J Clin Invest       Date:  1965-02       Impact factor: 14.808

5.  [Prothrombin: a unit or complex?].

Authors:  D Voss
Journal:  Klin Wochenschr       Date:  1967-05-01

6.  Immediate effect of components from the interior of human cells on blood coagulation.

Authors:  N Clarke; M Collins
Journal:  Ir J Med Sci       Date:  1971-02       Impact factor: 1.568

7.  Methyl isocyanate inhalation induces tissue factor-dependent activation of coagulation in rats.

Authors:  Raymond C Rancourt; Jacqueline S Rioux; Livia A Veress; Rhonda B Garlick; Claire R Croutch; Eric Peters; William Sosna; Carl W White
Journal:  Drug Chem Toxicol       Date:  2018-11-14       Impact factor: 3.356

Review 8.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

9.  Crystallization and preliminary X-ray crystallographic analysis of blood coagulation factor V-activating proteinase (RVV-V) from Russell's viper venom.

Authors:  Daisuke Nakayama; Youssef Ben Ammar; Soichi Takeda
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-11-27

10.  The effect of phospholipase C on human blood platelets.

Authors:  A B Otnaess; T Holm
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.